ACM
TBPH icon

Aquatic Capital Management’s Theravance Biopharma TBPH Stock Holding History

Aquatic Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$529K Buy
+32,599
New +$577K 0.02% 741
2025
Q4 		– Sell
-16,768
Closed -$245K – 1762
2025
Q3 		$245K Sell
16,768
-19,476
-54% -$246K ﹤0.01% 1053
2025
Q2 		$400K Buy
36,244
+16,386
+83% +$159K 0.01% 877
2025
Q1 		$177K Buy
19,858
+17,254
+663% +$161K ﹤0.01% 963
2024
Q4 		$24.5K Buy
+2,604
New +$23.7K ﹤0.01% 1227
2024
Q3 		– Sell
-500
Closed -$4.24K – 1532
2024
Q2 		$4.24K Sell
500
-1,400
-74% -$12.6K ﹤0.01% 1148
2024
Q1 		$17K Buy
+1,900
New +$17.6K ﹤0.01% 1112
2023
Q4 		– Sell
-1,600
Closed -$14K – 1622
2023
Q3 		$14K Buy
+1,600
New +$15.4K ﹤0.01% 1105

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return